I hope my set of #RedemptionWeek threads on #ClinicalTrials and #Methodology has been in some way useful to a couple of people. It’s certainly been cathartic for me.
6/6
A bonus following my #RedemptionWeek:
I’m highlighting a short paper that can be used for teaching caution in #ClinicalTrial subgroups:
“‘Thursday’s child has far to go’—interpreting subgroups and the #STAMPEDEtrial” https://www.annalsofoncology.org/article/S0923-7534(19)34965-8/fulltext
1/6
I’ll be back to wrap up my (rather stretched out) #Methodology #ClinicalTrials #RedemptionWeek
11/11
Day 3 #RedemptionWeek for #ClinicalTrials #Methodology papers focuses on oversight of #ClinicalTrials.
Robust clinical trial oversight is critical to the validity
and safety of trials. Clear oversight structures benefit trials.
1/12
On Day 3 of #RedemptionWeek, we’ll talk about trial oversight.
5/5
On Day 2 #RedemptionWeek, I share our review of healthcare systems data (HSD; sometimes called routinely-collected healthcare data – RCHD), for clinical trials in the UK, led by @SarahLensen
#routinedata #healthdata
1/5
Matt Sydes